20.500.12556/DiRROS-17862 The urokinase-type plasminogen activator, its inhibitors and its receptor - the new prognostic factors in solid cancers The urokinase-type plasminogen activator (uPA), its inhibitors (PAI-1 and PAI-2) and its receptor (uPAR) play nan important role in the degradation of the intercellular tissue, the process which affects the ability of cancer cells to invade to surrounding tissue and to metastasize. The results of clinical studies performed in the past few years point out a significant influence of uPA, PAI-1, PAI-2 and uPAR on the course of the disease and survival of patients with solid tumours, particularly breast cancer. Hopefullythe categorization of patients according to the content of the serineproteases and its inhibitors in tumour tissues could provide a basis formore rational treatment planning and thus improving patients' survival. true false true Slovenian Medical Society - Section of Radiology ; Croatian Medical Association - Croatian Society of Radiology Ljubljana Angleški jezik Ni določen by Authors Neznano 2024-01-18 10:11:40 2024-01-18 10:11:41 2024-01-19 03:36:20 0000-00-00 00:00:00 1997 0 0 BSDOCID33135; str. 298-304 št. 3 Letn. 31 1997 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 1997-01-01 61 1318-2099 7386329 RAZ_Borstnar_Simona_1997.pdf RAZ_Borstnar_Simona_1997.pdf 1 C327233C8EEFB96DA5856D417CFCA7D5 69bec0c8421504d2c877951400fec891db71015de4c1b3fe744b4364edcb5c1e c751c0f8-b5e1-11ee-b0d4-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=24224 Onkološki inštitut Ljubljana 0 0 0